1. Ponciri Fructus Immatarus Sensitizes the Apoptotic Effect of Hyperthermia Treatment in AGS Gastric Cancer Cells through ROS-Dependent HSP Suppression
   Chae Ryeong Ahn et al, 2023, Biomedicines CrossRef
2. Role of Ganetespib, an HSP90 Inhibitor, in Cancer Therapy: From Molecular Mechanisms to Clinical Practice
   Mahmoud E. Youssef et al, 2023, IJMS CrossRef
3. Target- and prodrug-based design for fungal diseases and cancer-associated fungal infections
   Na Liu et al, 2023, Advanced Drug Delivery Reviews CrossRef
4. TTT (Tel2-Tti1-Tti2) Complex, the Co-Chaperone of PIKKs and a Potential Target for Cancer Chemotherapy
   Sankhadip Bhadra et al, 2023, IJMS CrossRef
5. Cytokine-Induced Killer Cells in Combination with Heat Shock Protein 90 Inhibitors Functioning via the Fas/FasL Axis Provides Rationale for a Potential Clinical Benefit in Burkitt’s lymphoma
   Fangfang Ge et al, 2023, IJMS CrossRef
6. Targeting Histone Deacetylases 6 in Dual-Target Therapy of Cancer
   Milan Beljkas et al, 2023, Pharmaceutics CrossRef
7. Heat-shock protein 90α protects NME1 against degradation and suppresses metastasis of breast cancer
   Yanchao Zhang et al, 2023, Br J Cancer CrossRef
8. Mutant p53-ENTPD5 control of the calnexin/calreticulin cycle: a druggable target for inhibiting integrin-α5-driven metastasis
   Evangelos Pavlakis et al, 2023, J Exp Clin Cancer Res CrossRef
9. Early acquired resistance to EGFR-TKIs in lung adenocarcinomas before radiographic advanced identified by CT radiomic delta model based on two central studies
   Xiumei Li et al, 2023, Sci Rep CrossRef
10. HSP110 Inhibition in Primary Effusion Lymphoma Cells: One Molecule, Many Pro-Survival Targets
    Roberta Gonnella et al, 2023, Cancers CrossRef
11. Caspase-9 inhibition triggers Hsp90-based chemotherapy-mediated tumor intrinsic innate sensing and enhances antitumor immunity
    Jingyang Li et al, 2023, J Immunother Cancer CrossRef
12. Discovery of potent heat shock protein 90 (Hsp90) inhibitors: structure-based virtual screening, molecular dynamics simulation, and biological evaluation
    Yonghua Xu et al, 2023, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
13. Targeting the heat shock response induced by modulated electro-hyperthermia (mEHT) in cancer
    Pedro Viana et al, 2024, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
14. Transcriptome reveals the role of the htpG gene in mediating antibiotic resistance through cell envelope modulation in Vibrio mimicus SCCF01
    Zhenyang Qin et al, 2024, Front. Microbiol. CrossRef
15. Bacterial heat shock protein genes during induction chemotherapy in pediatric patients with acute lymphoblastic leukemia
    Katherine A Dunn et al, 2024, Future Oncology CrossRef
16. Drug repurposing screen identifies lonafarnib as respiratory syncytial virus fusion protein inhibitor
    Svenja M. Sake et al, 2024, Nat Commun CrossRef
17. Discovery of three-dimensional bicyclo[3.3.1]nonanols as novel heat shock protein 90 inhibitors
    Kazuki Miura et al, 2023, Bioorganic & Medicinal Chemistry CrossRef
18. Network pharmacology and molecular docking analysis of Catharanthus roseus compounds: Implications for non-small cell lung cancer treatment
    Ghaida Alsaif et al, 2024, Journal of King Saud University - Science CrossRef
19. Functions and Therapeutic Use of Heat Shock Proteins in Hepatocellular Carcinoma
    Ramakrushna Paul et al, 2024, Livers CrossRef
20. XQZ3, a Chlorella pyrenoidosa polysaccharide suppresses cancer progression by restraining mitochondrial bioenergetics via HSP90/AKT signaling pathway
    Long Sun et al, 2024, International Journal of Biological Macromolecules CrossRef
21. Recent developments of HSP90 inhibitors: an updated patent review (2020-present)
    Jianfeng Liu et al, 2024, Expert Opinion on Therapeutic Patents CrossRef
22. Hsp90 inhibition leads to an increase in surface expression of multiple immunological receptors in cancer cells
    Madison Wickenberg et al, 2024, Front. Mol. Biosci. CrossRef
23. New Insights into Hsp90 Structural Plasticity Revealed by cryoEM
    Karine Minari et al, 2024, BioChem CrossRef
24. FRET Assays for the Identification of C. albicans HSP90-Sba1 and Human HSP90α-p23 Binding Inhibitors
    Philip Kohlmann et al, 2024, Pharmaceuticals CrossRef
25. null
    Michael Thiele, 2024 CrossRef
26. HSP90 C-terminal domain inhibition promotes VDAC1 oligomerization via decreasing K274 mono-ubiquitination in Hepatocellular Carcinoma
    Jinxin Zhang et al, 2023, Neoplasia CrossRef
27. Synthesis and Experimental Structure of a Multifunctional Catechol‐Azomethinebenzoic Acid, DFT/DMol3 Calculations, and Molecular Docking with Hsp90
    Hana Bashir Shawish et al, 2024, ChemistrySelect CrossRef
28. HSP70-mediated mitochondrial dynamics and autophagy represent a novel vulnerability in pancreatic cancer
    Giulia D. S. Ferretti et al, 2024, Cell Death Differ CrossRef
29. Novel tropane analogues as Hsp90 inhibitors targeting colon cancer: Synthesis, biological estimation, and molecular docking study
    Samar J. Almehmadi et al, 2024, Bioorganic Chemistry CrossRef
30. Testis-specific serine kinase 6 (TSSK6) is abnormally expressed in colorectal cancer and promotes oncogenic behaviors
    Magdalena Delgado et al, 2024, Journal of Biological Chemistry CrossRef
31. Polymer Conjugate as the New Promising Drug Delivery System for Combination Therapy against Cancer
    Qiang Hu et al, 2024, CTMC CrossRef
32. Pharmacokinetics, Dose-Proportionality, and Tolerability of Intravenous Tanespimycin (17-AAG) in Single and Multiple Doses in Dogs: A Potential Novel Treatment for Canine Visceral Leishmaniasis
    Marcos Ferrante et al, 2024, Pharmaceuticals CrossRef
33. An update on the status of HSP90 inhibitors in cancer clinical trials
    Shraddha Rastogi et al, 2024, Cell Stress and Chaperones CrossRef
34. Pd‐Catalyzed Coupling of Bromo‐N‐ (β‐glucopyranosyl)quinolin‐2‐ones with Amides: Synthesis of N‐glucosyl‐6BrCaQ Conjugates with Potent Anticancer Activity
    Wafa Redjdal et al, 2024, ChemMedChem CrossRef
35. A Cullin 5-based complex serves as an essential modulator of ORF9b stability in SARS-CoV-2 replication
    Yuzheng Zhou et al, 2024, Sig Transduct Target Ther CrossRef
36. Development of a Humanized Antibody Targeting Extracellular HSP90α to Suppress Endothelial-Mesenchymal Transition-Enhanced Tumor Growth of Pancreatic Adenocarcinoma Cells
    Chi-Shuan Fan et al, 2024, Cells CrossRef
37. Lung Adenocarcinoma Systems Biomarker and Drug Candidates Identified by Machine Learning, Gene Expression Data, and Integrative Bioinformatics Pipeline
    Semra Melis Soyer et al, 2024, OMICS: A Journal of Integrative Biology CrossRef
38. Polygonatum sibiricum component liquiritigenin restrains breast cancer cell invasion and migration by inhibiting HSP90 and chaperone-mediated autophagy
    Suli Xu et al, 2024, Korean J Physiol Pharmacol CrossRef
39. Research Progress on the Role of Hsp90α in Cancer Development and Treatment
    思远 常, 2024, ACM CrossRef
40. Dithiothreitol-Based Protein Equalisation in the Context of Multiple Myeloma: Enhancing Proteomic Analysis and Therapeutic Insights.
    Inês F. Domingos et al, 2024, Talanta CrossRef
41. HSP47 in human diseases: Navigating pathophysiology, diagnosis and therapy
    Essak. S. Khan et al, 2024, Clinical & Translational Med CrossRef
42. null
    Neena G. Shetake et al, 2024 CrossRef
43. Antagonistic interaction of HSP90 inhibitor XL-888 and 5-FU combination treatment in breast cancer cells
    Nazan Gökşen Tosun, 2024, Int. Adv. Res. Eng. J. CrossRef
44. Discovery of new Hsp90–Cdc37 protein–protein interaction inhibitors: in silico screening and optimization of anticancer activity
    Jaka Dernovšek et al, 2024, RSC Adv. CrossRef
45. Synthesis, molecular docking, dynamics study and preliminary cytotoxicity study of some coumarin linked imidazothiadiazoles
    Sujeet Kumar et al, 2024, Journal of Molecular Structure CrossRef
46. Targeting HSP90 in Gynecologic Cancer: Molecular Mechanisms and Therapeutic Approaches
    Lu Min et al, 2024, Cell Biochem Biophys CrossRef
47. Targeting HSP90 for Cancer Therapy: Current Progress and Emerging Prospects
    Xinqi Liang et al, 2024, J. Med. Chem. CrossRef
48. null
    Nadia M. Hamdy et al, 2024 CrossRef
49. Development and Preclinical Evaluation of 18F-Labeled PEGylated Sansalvamide A Decapeptide for Noninvasive Evaluation of Hsp90 Status in Pancreas Cancer
    Xiaohui Wang et al, 2024, Mol. Pharmaceutics CrossRef
50. HSP90 promotes tumor associated macrophage differentiation during triple-negative breast cancer progression
    Lingjia Hong et al, 2024, Sci Rep CrossRef
51. Molecular chaperones: Guardians of tumor suppressor stability and function
    Jennifer A. Heritz et al, 2024, Oncotarget CrossRef
52. null
    Michael Thiele, 2024 CrossRef
53. Hiding in plain sight: Optimizing topoisomerase IIα inhibitors into Hsp90β selective binders
    Jaka Dernovšek et al, 2024, European Journal of Medicinal Chemistry CrossRef
54. Functional and therapeutic significant of heat-shock protein 90 (HSP90) in reproductive cancers
    Ben-Zhen He et al, 2024, Clin Transl Oncol CrossRef
55. Correlation between lncRNAs with human molecular chaperons in cancer immunopathogenesis and drug resistance
    Chou-Yi Hsu et al, 2024, International Immunopharmacology CrossRef
56. Human Target Proteins for Benzo(a)pyrene and Acetaminophen (And Its Metabolites): Insights from Inverse Molecular Docking and Molecular Dynamics Simulations
    Yina Montero-Pérez et al, 2024, Sci. Pharm. CrossRef
57. HSP90 N-terminal inhibition promotes mitochondria-derived vesicles related metastasis by reducing TFEB transcription via decreased HSP90AA1-HCFC1 interaction in liver cancer
    Lixia Liu et al, 2024, Autophagy CrossRef
58. Harnessing bacterial metabolites for enhanced cancer chemotherapy: unveiling unique therapeutic potentials
    Aroni Chatterjee et al, 2024, Arch Microbiol CrossRef
59. PU-H71 (NSC 750424): a molecular masterpiece that targets HSP90 in cancer and beyond
    Sameh Saber et al, 2024, Front. Pharmacol. CrossRef
60. Innovations and Emerging Trends in Prostate Cancer Management: A Literature Review
    Nazeer Ibraheem et al, 2024 CrossRef
61. Profiling the Misfolded Proteome in Human Disease
    Vivian C. Onwudiwe et al, 2024, Israel Journal of Chemistry CrossRef
62. Investigation of the anti-cancer potential of epoxyazadiradione in neuroblastoma: experimental assays and molecular analysis
    Shivani Chandel et al, 2024, Journal of Biomolecular Structure and Dynamics CrossRef
63. The Role of eHsp90 in Extracellular Matrix Remodeling, Tumor Invasiveness, and Metastasis
    Pragya Singh et al, 2024, Cancers CrossRef
64. Discovery of N-Aryl-Benzimidazolone Analogs as Novel Potential HSP90 Inhibitors: A Computational Approach
    Radhia Mazri et al, 2024, Applied Sciences CrossRef
65. Chemical probes for the identification of the molecular targets of honokiol
    Henar Vázquez-Villa et al, 2024, European Journal of Medicinal Chemistry CrossRef
66. Synthesis, biological evaluation and mechanism study based on network pharmacology of amino acids esters of 20(S)-protopanaxadiol as novel anticancer agents
    Hongliu Xie et al, 2025, Fitoterapia CrossRef
67. AKT kinases as therapeutic targets
    Dalal Hassan et al, 2024, J Exp Clin Cancer Res CrossRef
68. Unveiling the HSF1 Interaction Network: Key Regulators of Its Function in Cancer
    Snezhana A. Vladimirova et al, 2024, Cancers CrossRef
69. Remodeling of tumour microenvironment: strategies to overcome therapeutic resistance and innovate immunoengineering in triple-negative breast cancer
    Desh Deepak Singh et al, 2024, Front. Immunol. CrossRef
70. High-throughput screening identifies a novel small molecule modulator of Hsp70 that selectively enhances ubiquitination and degradation of misfolded neuronal NO synthase
    Anthony M. Garcia et al, 2024, Molecular Pharmacology CrossRef
71. AKT and the Hallmarks of Cancer
    Eleonora Sementino et al, 2024 CrossRef
72. Ligand-based pharmacophore modelling, structure optimisation, and biological evaluation for the identification of 2-heteroarylthio- N -arylacetamides as novel HSP90 C-terminal inhibitors
    Yajun Liu et al, 2024, Journal of Enzyme Inhibition and Medicinal Chemistry CrossRef
73. Conformationally Restricted Grp94-Selective Inhibitors
    Hao Xu et al, 2025, ACS Omega CrossRef
74. Natural products targeting RAS by multiple mechanisms and its therapeutic potential in cancer: An update since 2020
    Yanqing Liu et al, 2025, Pharmacological Research CrossRef
75. Dual targeting of HSP90 and BCL-2 in breast cancer cells using inhibitors BIIB021 and ABT-263
    Nazan Gökşen Tosun et al, 2025, Breast Cancer Res Treat CrossRef